TY - JOUR
T1 - Mutation Rate of Normal and Malignant Human Lymphocytes
AU - Seshadri, Ram
AU - Kutlaca, Robert J.
AU - Trainor, Kevin
AU - Matthews, Chris
AU - Morley, Alexander A.
PY - 1987/1/15
Y1 - 1987/1/15
N2 - The genetic stability of normal and neoplastic lymphocytes was compared by using base-line mutation frequency and mutation rate/cell generation. Mutations at the hypoxanthine-guanine phosphoribosyltransferase locus were studied by enumerating thioguanine-resistant cells in a clonogenic assay. The base-line (“spontaneous”) mutation frequency was 1.52 x 10-6, 6.38 x 10-6, and 1.06 x 10-6 for normal cells from three individuals and was 1.16 x 10-3, 6.08 x 10-5, and 3.06 x 10-5 for the three malignant cell lines, Jurkat (JM), HRIK, FMC-Hu1B, respectively. The mutation cell/generation rate was 24.6 x 10-6, 15 x 10-8, and 5.5 x 10-8 for lymphocytes from the three normal individuals, and 666.4 x 10-8, 52.8 x 10-8, and 131 x 10-8 for the three malignant cell lines. The results suggest that neoplastic lymphocytes are more genetically unstable than normal lymphocytes.
AB - The genetic stability of normal and neoplastic lymphocytes was compared by using base-line mutation frequency and mutation rate/cell generation. Mutations at the hypoxanthine-guanine phosphoribosyltransferase locus were studied by enumerating thioguanine-resistant cells in a clonogenic assay. The base-line (“spontaneous”) mutation frequency was 1.52 x 10-6, 6.38 x 10-6, and 1.06 x 10-6 for normal cells from three individuals and was 1.16 x 10-3, 6.08 x 10-5, and 3.06 x 10-5 for the three malignant cell lines, Jurkat (JM), HRIK, FMC-Hu1B, respectively. The mutation cell/generation rate was 24.6 x 10-6, 15 x 10-8, and 5.5 x 10-8 for lymphocytes from the three normal individuals, and 666.4 x 10-8, 52.8 x 10-8, and 131 x 10-8 for the three malignant cell lines. The results suggest that neoplastic lymphocytes are more genetically unstable than normal lymphocytes.
UR - http://www.scopus.com/inward/record.url?scp=0023135430&partnerID=8YFLogxK
M3 - Article
C2 - 3466691
AN - SCOPUS:0023135430
SN - 0008-5472
VL - 47
SP - 407
EP - 409
JO - Cancer Research
JF - Cancer Research
IS - 2
ER -